186 related articles for article (PubMed ID: 36755068)
1. MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis.
Nguyen HV; Vandenberg CJ; Robati MR; Ng AP; Cory S
Cell Death Differ; 2023 Apr; 30(4):1018-1032. PubMed ID: 36755068
[TBL] [Abstract][Full Text] [Related]
2. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S
Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211
[TBL] [Abstract][Full Text] [Related]
3. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
4. Mnt modulates Myc-driven lymphomagenesis.
Campbell KJ; Vandenberg CJ; Anstee NS; Hurlin PJ; Cory S
Cell Death Differ; 2017 Dec; 24(12):2117-2126. PubMed ID: 28800127
[TBL] [Abstract][Full Text] [Related]
5. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
[TBL] [Abstract][Full Text] [Related]
6. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.
Dezfouli S; Bakke A; Huang J; Wynshaw-Boris A; Hurlin PJ
Mol Cell Biol; 2006 Mar; 26(6):2080-92. PubMed ID: 16507988
[TBL] [Abstract][Full Text] [Related]
8. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
9. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
Link JM; Hurlin PJ
Biochim Biophys Acta; 2015 May; 1849(5):554-62. PubMed ID: 24731854
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
11. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
12. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
[TBL] [Abstract][Full Text] [Related]
13.
Mathsyaraja H; Freie B; Cheng PF; Babaeva E; Catchpole JT; Janssens D; Henikoff S; Eisenman RN
Genes Dev; 2019 Sep; 33(17-18):1252-1264. PubMed ID: 31395740
[TBL] [Abstract][Full Text] [Related]
14. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.
Potts MA; Mizutani S; Garnham AL; Li Wai Suen CSN; Kueh AJ; Tai L; Pal M; Strasser A; Herold MJ
Cell Death Differ; 2023 Jun; 30(6):1447-1456. PubMed ID: 36894688
[TBL] [Abstract][Full Text] [Related]
16. A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.
Link JM; Ota S; Zhou ZQ; Daniel CJ; Sears RC; Hurlin PJ
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19685-90. PubMed ID: 23150551
[TBL] [Abstract][Full Text] [Related]
17. Uncovering MYC's full oncogenic potential in the hematopoietic system.
Janz S
Oncogene; 2005 May; 24(22):3541-3. PubMed ID: 15782131
[TBL] [Abstract][Full Text] [Related]
18. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
[TBL] [Abstract][Full Text] [Related]
19. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
20. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
Frenzel A; Labi V; Chmelewskij W; Ploner C; Geley S; Fiegl H; Tzankov A; Villunger A
Blood; 2010 Feb; 115(5):995-1005. PubMed ID: 19965635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
